What's New

September 22, 2021

HNL Career Fair

Interested in a career at HNL Lab Medicine?

Join us at our next Career Fair, Wednesday, September 29, 2021 at 1 pm – 5:30 pm.

Located at 794 Roble Rd, Allentown, PA 18109-9110 (PARKING LOT)
On-the-spot interviews will be conducted

Read More
September 08, 2021

Martin K. Till, New President and CEO of HNL Lab Medicine, Starts with Strategic Plan to Accelerate Growth


HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the official start of Martin K. Till as president and CEO, transitioning from Matthew R. Sorrentino, Esq., who will retire Oct. 15 and continue in a consulting capacity for the next year.

Read More
July 16, 2021

HNL Lab Medicine Announces a New Patient Service Center in Hazleton, Pa.

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the opening of a patient center at 550 West Broad Street, Hazleton, Luzerne County. Patients can access this facility Monday to Friday from 7 a.m. to 5 p.m. and Saturdays 8 a.m. to noon. https://www.hnl.com/Hazleton 

Read More
July 07, 2021

HNL Lab Medicine Announces New Patient Service Center Location in Gateway Plaza, Chambersburg, Pa.

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, is moving its Chambersburg patient center to the new Gateway Plaza, 497 Gateway Avenue. Patients can access this facility weekdays from 6 a.m. to 3:30 p.m. and Saturdays 7 a.m. to 11 a.m.
Read More
June 29, 2021

HNL Lab Medicine's Unseen Heroes

Presenting HNL Lab Medicine’s

Unseen Heroes Video — WATCH VIDEO

Read More

Shanth A. Goonewardene, MD

Vice Chair Quality and Clinical Operations; Chief, Section of Gastrointestinal Pathology
Dr. Goonewardene received his MD from Jefferson Medical College. He completed his pathology residency and surgical pathology fellowship (with focus in Gastrointestinal Pathology) at Thomas Jefferson University Hospital, Philadelphia, Pa. He then completed a Fellowship in Cytopathology at the Hospital of the University of Pennsylvania, Philadelphia, Pa. He is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added board certification in Cytopathology. Dr. Goonewardene serves as Director of the Anatomic Pathology Quality Assurance Committee at Lehigh Valley Health Network. His research and publications focus on gastrointestinal pathology. He is currently investigating the use of molecular markers in increasing the sensitivity of detecting pancreatic adenocarcinoma in fine needle aspiration cytology specimens. Dr. Shanth Goonewardene is a Clinical Assistant Professor at University of South Florida (USF), Morsani College of Medicine.



The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients t reated with surgery alone.
Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.Cancer. 2004 Jun 1;100(11):2317-27. PMID: 15160334 Free Article

Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Zimmerman RL,Goonewardene S, Fogt F. Mod Pathol. 2001 Aug;14(8):748-51. PMID:11504833 Free Article

Diagnostic utility of BCA-225 in detecting adenocarcinoma in serous effusions.
Zimmerman RL, Goonewardene S,Fogt F. Anal Quant Cytol Histol. 2000 Oct;22(5):353-7. PMID:11064810

Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
Zimmerman RL, Fogt F, Goonewardene S. Cancer. 2000 Aug 25;90(4):230-4. PMID:10966563